The ENABLE trial, conducted in rural regions of Vermont and New Hampshire, reports a positive impact on the 1-year survival of advanced cancer patients. A parallel study, ENABLE III, reported benefits to caregivers following early introduction of palliative care in these advanced cancer patients.
Early concurrent palliative care (PC) in patients with advanced cancer had a significantly beneficial effect on 1-year survival, even for patients living in a remote rural setting, according to results from the ENABLE trial. The 1-year survival rate was 63% for those who received early PC compared with 48% in the group that received delayed care (15% difference, P = .038), reported J. Nicholas Dionne-Odom, PhD, of the University of Alabama in Birmingham, and colleagues.
Most of the patients lived in rural New Hampshire or Vermont, making ENABLE "the only feasible and effective telehealth early [palliative care] model for patients with advanced cancer and family caregivers in a rural setting," the authors wrote in the Journal of Clinical Oncology.
Link to the report on Medpage Today:
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen